Author

Kowshik Jaganathan

Observed name: Jaganathan Kowshik

Observed institution: Annamalai University

OpenAlex ID: A5059377412

Nimbolide upregulates RECK by targeting miR-21 and HIF-1α in cell lines and in a hamster oral carcinogenesis model

2017 · Jaganathan Kowshik, Rajakishore Mishra, et al. · Scientific Reports · 144

Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer

2018 · Josephraj Sophia, Jaganathan Kowshik, et al. · Cell Death and Disease · 129

PDF

Ellagic Acid Inhibits VEGF/VEGFR2, PI3K/Akt and MAPK Signaling Cascades in the Hamster Cheek Pouch Carcinogenesis Model

2014 · Jaganathan Kowshik, Hemant Giri, et al. · Anti-Cancer Agents in Medicinal Chemistry · 77

Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF‐κΒ/STAT3 signalling axis in oral squamous cell carcinoma models

2019 · Jaganathan Kowshik, Ramesh Nivetha, et al. · IUBMB Life · 63

PDF

Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis

2016 · Josephraj Sophia, Kranthi Kiran Kishore T., et al. · Scientific Reports · 44

PDF

Blueberry inhibits invasion and angiogenesis in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral squamous cell carcinogenesis in hamsters via suppression of TGF-β and NF-κB signaling pathways

2016 · Abdul Basit Baba, Jaganathan Kowshik, et al. · The Journal of Nutritional Biochemistry · 34

The Hamster Buccal Pouch Model of Oral Carcinogenesis

2016 · Siddavaram Nagini, Jaganathan Kowshik · Methods in molecular biology · 26

Gedunin, A Neem Limonoid in Combination with Epalrestat Inhibits Cancer Hallmarks by Attenuating Aldose Reductase-Driven Oncogenic Signaling in SCC131 Oral Cancer Cells

2019 · Kranthi K.K. Tanagala, Abdul B. Baba, et al. · Anti-Cancer Agents in Medicinal Chemistry · 25

Activation of PI3K/Akt/NF-kB Signaling Mediates Swedish Snus Induced Proliferation and Apoptosis Evasion in the Rat Forestomach: Modulation by Blueberry

2019 · Singaraj Ranjani, Jaganathan Kowshik, et al. · Anti-Cancer Agents in Medicinal Chemistry · 16

Exposure to welding fumes activates DNA damage response and redox-sensitive transcription factor signalling in Sprague-Dawley rats

2017 · Jayaraman Krishnaraj, Jaganathan Kowshik, et al. · Toxicology Letters · 14

Tumor histoculture captures the dynamic interactions between tumor and immune components in response to anti-PD1 in head and neck cancer

2024 · Nandini Pal Basak, Kowshik Jaganathan, et al. · Nature Communications · 9

PDF

448 Extracellular vesicles from the tumor treated with anti-PD1 therapy, confers intratumoral immune response phenotype on to unrelated PBMCs

2026 · Satish Sankaran, Kowshik Jaganathan, et al. · Journal for ImmunoTherapy of Cancer

PDF

Abstract 6549: Integrating functional biosignatures and same-cell spatial multiomics to predict synergistic benefit of combination checkpoint therapy in head and neck cancer

2026 · Yi Cui, Moumita Nath, et al. · Cancer Research

Abstract 7761: Tertiary lymphoid structure (TLS) representative cells elicit response to anti-PD-1+ therapy in a cold tumor

2026 · Satish Sankaran, Priyanka Chevour, et al. · Cancer Research

475 Understanding the role of tumor immune microenvironment in determining response to immune checkpoint inhibitor in colorectal cancer

2025 · Satish Sankaran, M Dharanidharan, et al. · Journal for ImmunoTherapy of Cancer

PDF

Abstract 5807: Differential T cell response to anti-PD1 in breast cancer Sub-types is driven by activity of intra-tumoral immune cells

2025 · Mouniss MM, Biswajit Das, et al. · Cancer Research

Abstract B030: Identification of tumor microenvironment informed exosome biomarkers for predicting response to anti-PD1 therapy

2025 · Kowshik Jaganathan, Moumita Nath, et al. · Cancer Research

822 Identifying and targeting resistance factors upon immune checkpoint inhibition for better combinatorial treatment strategies leading to improved outcomes

2024 · Moumita Nath, Biswajit Das, et al. · Journal for ImmunoTherapy of Cancer

823 PLN-101095 a selective inhibitor of integrins αvβ8 and αvβ1 augments the therapeutic benefits of immune checkpoint blockade therapy in human tumor histoculture model

2024 · Nandini P Basak, Juby, et al. · Journal for ImmunoTherapy of Cancer

Abstract 3843: Role of CD4/CD8 double positive T cells in modulating response to anti-PD-1 treatment in renal cell carcinoma

2024 · Satish Sankaran, Kowshik Jaganathan, et al. · Cancer Research

Abstract A018: Characterization of macrophage population in head and neck squamous cell carcinoma and renal cell carcinoma and their role in modulating immune checkpoint blockade response

2023 · Moumita Nath, Nandini Pal Basak, et al. · Cancer Immunology Research

1104 Identification of effective treatment regimens for ovarian cancer using tumor histoculture platform

2023 · Biswajit Das, Kowshik Jaganathan, et al. · Journal for ImmunoTherapy of Cancer

PDF

462 Pre-selection of patients who would respond to combination of chemotherapy and low dose immunotherapy using human histoculture platform

2023 · Kowshik Jaganathan, Biswajit Das, et al. · Journal for ImmunoTherapy of Cancer

PDF

Abstract 4568: Evaluating response of renal cell carcinoma to tyrosine kinase inhibitor and immune checkpoint inhibitor using a human histo-culture platform

2023 · Satish Sankaran, Kowshik Jaganathan, et al. · Cancer Research

Abstract 6632: Simultaneous comparison of response to two different anti-PD1 drugs in the same patient using a human tumor histo-culture platform

2023 · Satish Sankaran, Biswajit Das, et al. · Cancer Research

Works count: 30

Citation count: 581

H-index: 10

I10-index: 10